Tapewire

Nasdaq · USD

INSM

INSMED Inc

Export transactions ↓
Tapewire entity
3174
SEC CIK
0001104506
Parsed reports
490

Last 12 months

Inside the activity.

0 purchase rows · 169 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025023
Dec 2025018
Jan 2026044
Feb 2026022
Mar 202608
Apr 2026010
May 2026019
Jun 2026013
Jul 202607
Aug 202604
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 03, 2020 Filed Jan 7, 2020 23:12 UTC
Pellizzari Christine AChief Legal Officer
GrantCommon Stock 26,315 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-20-000025 · edgar.xml · nonDerivative · entry 1

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,658

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3 · balance_after: Includes 1,789 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:13 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantStock Option (right to buy) · Derivative 56,520 $0.00 Strike: $23.75 $0.00
Disclosure

SEC source: 0001127430-20-000026 · edgar.xml · derivative · entry 3

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,520

Underlying: Common Stock · 56,520 shares

Expires 2030-01-03

F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:13 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
Tax withholdingCommon Stock 979 $23.75 $23,251.25
Disclosure

SEC source: 0001127430-20-000026 · edgar.xml · nonDerivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,552

F4 · price: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:13 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantCommon Stock 10,526 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-20-000026 · edgar.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,531

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3 · balance_after: Includes 1,655 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:12 UTC
Lewis WilliamDirector · Chairman and CEO
GrantStock Option (right to buy) · Derivative 282,590 $0.00 Strike: $23.75 $0.00
Disclosure

SEC source: 0001127430-20-000024 · edgar.xml · derivative · entry 2

Lewis William · CIK 0001402051 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,590

Underlying: Common Stock · 282,590 shares

Expires 2030-01-03

F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:12 UTC
Lewis WilliamDirector · Chairman and CEO
GrantCommon Stock 52,631 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-20-000024 · edgar.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,092

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3 · balance_after: Includes 1,789 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:05 UTC
Adsett RogerChief Operating Officer
GrantStock Option (right to buy) · Derivative 141,300 $0.00 Strike: $23.75 $0.00
Disclosure

SEC source: 0001127430-20-000021 · edgar.xml · derivative · entry 3

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,300

Underlying: Common Stock · 141,300 shares

Expires 2030-01-03

F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:05 UTC
Adsett RogerChief Operating Officer
Tax withholdingCommon Stock 1,414 $23.75 $33,582.50
Disclosure

SEC source: 0001127430-20-000021 · edgar.xml · nonDerivative · entry 2

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,721

F3 · price: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:05 UTC
Adsett RogerChief Operating Officer
GrantCommon Stock 26,315 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-20-000021 · edgar.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,135

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:09 UTC
Flammer Martina M.D.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 56,520 $0.00 Strike: $23.75 $0.00
Disclosure

SEC source: 0001127430-20-000022 · edgar.xml · derivative · entry 2

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,520

Underlying: Common Stock · 56,520 shares

Expires 2030-01-03

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:09 UTC
Flammer Martina M.D.Chief Medical Officer
GrantCommon Stock 10,526 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-20-000022 · edgar.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,526

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant for four years.

F2 · price: Each Restricted Stock Unit was granted on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:06 UTC
Flammer Martina M.D.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 150,990 $0.00 Strike: $23.66 $0.00
Disclosure

SEC source: 0001127430-20-000007 · edgar.xml · derivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,990

Underlying: Common Stock · 150,990 shares

Expires 2030-01-02

F1 · derivative.exercise_date: In connection with the appointment of Dr. Flammer as the Company's Chief Medical Officer, the Company granted Dr. Flammer an option to purchase a total of 150,990 shares of the Company's common stock. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Dr. Flammer's continued employment with the Company on each vesting date.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 21:12 UTC
Adsett RogerChief Operating Officer
GrantCommon Stock 24,863 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000133 · edgar.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,820

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: 100% on the third anniversary of the date of grant.

F2 · price: Each Restricted Stock Unit was granted on November 18, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3 · balance_after: Includes 1,789 shares acquired through the Company's 2018 Employee Stock Purchase Plan for the six-month period ended July 31, 2019.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 21:10 UTC
GOLL JOHNChief Accounting Officer
Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $12.58 $0.00
Disclosure

SEC source: 0001127430-19-000131 · edgar.xml · derivative · entry 3

GOLL JOHN · CIK 0001779466 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2024-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted under the Company's 2013 Incentive Plan. These stock options are currently exercisable

Read SEC document
November 18, 2019 Filed Nov 20, 2019 21:10 UTC
GOLL JOHNChief Accounting Officer
SaleStock Option 25,000 $20.04 $501,000.00
Disclosure

SEC source: 0001127430-19-000131 · edgar.xml · nonDerivative · entry 2

GOLL JOHN · CIK 0001779466 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,322

F1 · price: This is the weighted average sales price representing 25,000 shares sold at prices ranging from $19.75 to $20.20 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 21:10 UTC
GOLL JOHNChief Accounting Officer
Exercise / conversionStock Option 25,000 $12.58 $314,500.00
Disclosure

SEC source: 0001127430-19-000131 · edgar.xml · nonDerivative · entry 1

GOLL JOHN · CIK 0001779466 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,322

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 12, 2019 Filed Nov 14, 2019 21:15 UTC GrantCommon Stock 5,295 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000120 · edgar.xml · nonDerivative · entry 1

Desjardins Clarissa · CIK 0001793390 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,295

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on November 12, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
June 25, 2019 Filed Jun 25, 2019 20:06 UTC
Lewis WilliamDirector · Chairman, President & CEO
Exercise / conversionStock Option (right to buy) · Derivative 277,684 $0.00 Strike: $3.40 $0.00
Disclosure

SEC source: 0001127430-19-000094 · edgar.xml · derivative · entry 3

Lewis William · CIK 0001402051 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 430,630

Underlying: Common Stock · 277,684 shares

Expires 2022-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options are currently exercisable.

Read SEC document
June 25, 2019 Filed Jun 25, 2019 20:06 UTC
Lewis WilliamDirector · Chairman, President & CEO
SaleCommon Stock 400,000 $26.00 $10,400,000.00
Disclosure

SEC source: 0001127430-19-000094 · edgar.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,672

F1 · shares: The reporting person sold the shares following the underwriter's exercise of an overallotment option in connection with a public offering by the issuer.

Read SEC document
June 25, 2019 Filed Jun 25, 2019 20:06 UTC
Lewis WilliamDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 277,684 $26.00 $7,219,784.00
Disclosure

SEC source: 0001127430-19-000094 · edgar.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 480,672

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 25, 2019 Filed Jun 26, 2019 20:50 UTC Amendment
Lewis WilliamDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 277,684 $3.40 $944,125.60
Disclosure

SEC source: 0001127430-19-000100 · edgar.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 480,672

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was inadvertently reported incorrectly on the original Form 4.

Read SEC document
June 06, 2019 Filed Jun 10, 2019 20:05 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
Exercise / conversionStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $6.96 $0.00
Disclosure

SEC source: 0001127430-19-000083 · edgar.xml · derivative · entry 3

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,226

Underlying: Common Stock · 12,000 shares

Expires 2023-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted under the Company's 2000 Incentive Plan. These stock options are currently exercisable.

Read SEC document
June 06, 2019 Filed Jun 10, 2019 20:05 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
SaleStock Option 12,000 $23.24 $278,839.20
Disclosure

SEC source: 0001127430-19-000083 · edgar.xml · nonDerivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,350

F1 · price: This is the weighted average sales price representing 12,000 shares sold at prices ranging from $23.00 to $23.66 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

Read SEC document
June 06, 2019 Filed Jun 10, 2019 20:05 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
Exercise / conversionStock Option 12,000 $6.96 $83,520.00
Disclosure

SEC source: 0001127430-19-000083 · edgar.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:17 UTC
LEE LEODirector
GrantCommon Stock 6,899 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000077 · edgar.xml · nonDerivative · entry 1

LEE LEO · CIK 0001740789 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,965

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:18 UTC GrantCommon Stock 6,899 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000079 · edgar.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,693

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:17 UTC GrantCommon Stock 6,899 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000076 · edgar.xml · nonDerivative · entry 1

ENGELSEN STEINAR J · CIK 0001218860 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,202

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:18 UTC GrantCommon Stock 6,899 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000078 · edgar.xml · nonDerivative · entry 1

MCGIRR DAVID W J · CIK 0001219023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,261

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:16 UTC GrantCommon Stock 6,899 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000075 · edgar.xml · nonDerivative · entry 1

Brennan David R · CIK 0001609305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,221

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:16 UTC GrantCommon Stock 6,899 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000074 · edgar.xml · nonDerivative · entry 1

ANDERSON ELIZABETH M · CIK 0001758247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,017

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:15 UTC GrantCommon Stock 6,899 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000073 · edgar.xml · nonDerivative · entry 1

ALTOMARI ALFRED · CIK 0001285644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,841

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:15 UTC
SORIANO JOHNChief Compliance Officer
GrantCommon Stock 12,935 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000072 · edgar.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,892

F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant for four years.

F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3 · balance_after: Includes 957 shares acquired through the Company's 2018 Employee Stock Purchase Plan for the six-month period ended December 31, 2018.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:14 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantCommon Stock 14,660 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000071 · edgar.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,350

F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:12 UTC
Adsett RogerChief Commercial Officer
GrantCommon Stock 21,559 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000068 · edgar.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,168

F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3 · balance_after: Includes 1,015 shares acquired through the Company's 2018 Employee Stock Purchase Plan for the six-month period ended December 31, 2018.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:13 UTC
Pellizzari Christine AChief Legal Officer
GrantCommon Stock 25,870 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000070 · edgar.xml · nonDerivative · entry 1

Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,554

F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3 · balance_after: Includes 1,015 shares acquired through the Company's 2018 Employee Stock Purchase Plan for the six-month period ended December 31, 2018.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:13 UTC
Lewis WilliamDirector · President & CEO
GrantCommon Stock 51,741 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000069 · edgar.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,988

F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
April 09, 2019 Filed Apr 11, 2019 20:06 UTC Exercise / conversionStock Option (right to buy) · Derivative 6,286 $0.00 Strike: $3.03 $0.00
Disclosure

SEC source: 0001127430-19-000045 · edgar.xml · derivative · entry 3

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,714

Underlying: Common Stock · 6,286 shares

Expires 2021-12-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
April 09, 2019 Filed Apr 11, 2019 20:06 UTC SaleCommon Stock 6,286 $32.99 $207,375.14
Disclosure

SEC source: 0001127430-19-000045 · edgar.xml · nonDerivative · entry 2

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,197

F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
April 09, 2019 Filed Apr 11, 2019 20:06 UTC Exercise / conversionCommon Stock 6,286 $3.03 $19,046.58
Disclosure

SEC source: 0001127430-19-000045 · edgar.xml · nonDerivative · entry 1

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,483

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 26, 2019 Filed Feb 27, 2019 21:07 UTC SaleCommon Stock 5,500 $30.00 $165,000.00
Disclosure

SEC source: 0001127430-19-000040 · edgar.xml · nonDerivative · entry 1

ALTOMARI ALFRED · CIK 0001285644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,942

F1 · price: Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 22, 2019 Filed Feb 26, 2019 21:07 UTC Exercise / conversionStock Option (right to buy) · Derivative 14,900 $0.00 Strike: $3.03 $0.00
Disclosure

SEC source: 0001127430-19-000035 · edgar.xml · derivative · entry 3

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,100

Underlying: Common Stock · 14,900 shares

Expires 2021-12-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
February 22, 2019 Filed Feb 26, 2019 21:07 UTC SaleCommon Stock 14,900 $28.08 $418,392.00
Disclosure

SEC source: 0001127430-19-000035 · edgar.xml · nonDerivative · entry 2

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,197

F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 22, 2019 Filed Feb 26, 2019 21:07 UTC Exercise / conversionCommon Stock 14,900 $3.03 $45,147.00
Disclosure

SEC source: 0001127430-19-000035 · edgar.xml · nonDerivative · entry 1

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,097

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 21:05 UTC SaleCommon Stock 5,500 $27.50 $151,250.00
Disclosure

SEC source: 0001127430-19-000032 · edgar.xml · nonDerivative · entry 1

ALTOMARI ALFRED · CIK 0001285644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,442

F1 · price: Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 15, 2019 Filed Feb 27, 2019 21:08 UTC Exercise / conversionStock Option (right to buy) · Derivative 100 $0.00 Strike: $3.03 $0.00
Disclosure

SEC source: 0001127430-19-000041 · edgar.xml · derivative · entry 3

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,900

Underlying: Common Stock · 100 shares

Expires 2021-12-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant.

F3 · balance_after: Total does not reflect previously reported transactions that occurred after February 15, 2019. This report has been filed late due to a broker reporting error.

Read SEC document
February 15, 2019 Filed Feb 27, 2019 21:08 UTC SaleCommon Stock 100 $27.90 $2,790.00
Disclosure

SEC source: 0001127430-19-000041 · edgar.xml · nonDerivative · entry 2

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,197

F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 15, 2019 Filed Feb 27, 2019 21:08 UTC Exercise / conversionCommon Stock 100 $3.03 $303.00
Disclosure

SEC source: 0001127430-19-000041 · edgar.xml · nonDerivative · entry 1

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 05, 2019 Filed Feb 7, 2019 21:07 UTC SaleCommon Stock 5,500 $25.00 $137,500.00
Disclosure

SEC source: 0001127430-19-000029 · edgar.xml · nonDerivative · entry 1

ALTOMARI ALFRED · CIK 0001285644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,942

F1 · price: Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 10, 2019 Filed Jan 14, 2019 21:15 UTC SaleCommon Stock 5,500 $22.50 $123,750.00
Disclosure

SEC source: 0001127430-19-000025 · edgar.xml · nonDerivative · entry 1

ALTOMARI ALFRED · CIK 0001285644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,442

F1 · price: Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 04, 2019 Filed Jan 7, 2019 21:10 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
Tax withholdingCommon Stock 979 $14.85 $14,538.15
Disclosure

SEC source: 0001127430-19-000020 · edgar.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,690

F1 · price: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.